Cargando…

Clinical impact of complement (C1q, C3d) binding De Novo donor-specific HLA antibody in kidney transplant recipients

INTRODUCTION: Complement binding activity of donor-specific HLA antibodies (DSA) has been suggested as a new tool to stratify immunologic risk in kidney transplantation (KT). The objective of this study was to evaluate the clinical implication of C1q/C3d binding activity of de novo DSA (dnDSA) in KT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Hyeyoung, Han, Eunhee, Choi, Ae-Ran, Ban, Tae Hyun, Chung, Byung Ha, Yang, Chul Woo, Choi, Yeong Jin, Oh, Eun-Jee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235372/ https://www.ncbi.nlm.nih.gov/pubmed/30427941 http://dx.doi.org/10.1371/journal.pone.0207434

Ejemplares similares

Combined Analysis of HLA Class II Eplet Mismatch and Tacrolimus Levels for the Prediction of De Novo Donor Specific Antibody Development in Kidney Transplant Recipients
por: Lee, Hyeyoung, et al.
Publicado: (2022)

EDTA Treatment for Overcoming the Prozone Effect and for Predicting C1q Binding in HLA Antibody Testing
por: Kim, Hoon Seok, et al.
Publicado: (2019)

Impact of Low-Level Donor-Specific Anti-HLA Antibody on Posttransplant Clinical Outcomes in Kidney Transplant Recipients
por: Lee, Haeun, et al.
Publicado: (2023)

The Influence of Donor and Recipient Complement C3 Polymorphisms on Liver Transplant Outcome
por: Pires, Maria, et al.
Publicado: (2021)

Clinical Significance of HLA-DQ Antibodies in the Development of Chronic Antibody-Mediated Rejection and Allograft Failure in Kidney Transplant Recipients
por: Lee, Hyeyoung, et al.
Publicado: (2016)

Clinical risk stratification of paediatric renal transplant recipients using C1q and C3d fixing of de novo donor-specific antibodies
por: Kim, Jon Jin, et al.
Publicado: (2017)

Solid-Phase C1q/C3d Fixing Readouts Correlate with High Median Fluorescence Intensity (MFI) De Novo Donor-Specific HLA Antibodies and C4d(+) Antibody-Mediated Rejection in Kidney Transplant Recipients
por: Tatapudi, Vasishta S., et al.
Publicado: (2021)

Clinical Outcome of Kidney Transplant Recipients with C1q-Binding De Novo Donor Specific Antibodies: A Single-Center Experience
por: Marinaki, Smaragdi, et al.
Publicado: (2023)

Clinical significance of the presence of anti-human leukocyte antigen-donor specific antibody in kidney transplant recipients with allograft dysfunction
por: Chung, Byung Ha, et al.
Publicado: (2018)

Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients
por: Lee, Hyeyoung, et al.
Publicado: (2017)

Complement-Binding Donor-Specific Anti-HLA Antibodies: Biomarker for Immunologic Risk Stratification in Pediatric Kidney Transplantation Recipients
por: Sigurjonsdottir, Vaka K., et al.
Publicado: (2022)

The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients
por: O'Leary, Jacqueline G., et al.
Publicado: (2016)

The natural history of de novo donor-specific HLA antibodies after kidney transplantation
por: López del Moral, Covadonga, et al.
Publicado: (2022)

Impact of ABO Incompatibility on the Development of Acute Antibody-Mediated Rejection in Kidney Transplant Recipients Presensitized to HLA
por: Chung, Byung Ha, et al.
Publicado: (2015)

Technical Limitations of the C1q Single-Antigen Bead Assay to Detect Complement Binding HLA-Specific Antibodies
por: Taylor, Craig J., et al.
Publicado: (2017)

Association of Circulating Anti-HLA Donor-Specific Antibodies and Their Characteristics, including C1q-Binding Capacity, in Kidney Transplant Recipients with Long-Term Renal Graft Outcomes
por: Gniewkiewicz, Michal, et al.
Publicado: (2023)

Anti-HLA Donor-Specific IgG Subclasses and C1q-binding Evolution in Posttransplant Monitoring
por: Ponsirenas, Renata von Glehn, et al.
Publicado: (2018)

Trichinella spiralis Paramyosin Binds Human Complement C1q and Inhibits Classical Complement Activation
por: Sun, Ran, et al.
Publicado: (2015)

Hyper-IgM and acquired C1q complement deficiency in a patient with de novo ATM mutation
por: Lee, Adrian Y S, et al.
Publicado: (2023)

Clinical usefulness of kidney biopsy in liver transplant recipients with renal impairment
por: Lee, Jong Hoon, et al.
Publicado: (2013)

Complement, C1q, and C1q-Related Molecules Regulate Macrophage Polarization
por: Bohlson, Suzanne S., et al.
Publicado: (2014)

Importance and What to Watch Out for De Novo Donor Specific Anti-HLA Antibodies after Kidney Transplantation
por: Yang, Chul Woo
Publicado: (2018)

Nonimmunologic Donor-Recipient Pairing, HLA Matching, and Graft Loss in Deceased Donor Kidney Transplantation
por: Vinson, Amanda Jean, et al.
Publicado: (2018)

Complement C1q Enhances Primary Hemostasis
por: Donat, Claudia, et al.
Publicado: (2020)

De Novo Cytomegalovirus Colitis in a Donor-Seronegative/Recipient-Seronegative Kidney Transplant Recipient
por: Sulaiman, Zoheb I, et al.
Publicado: (2023)

Clinical significance of de novo donor-specific antibody in kidney transplant recipients with chronic antibody-mediated rejection
por: Park, Woo Yeong, et al.
Publicado: (2021)

Characteristics and Clinical Significance of De Novo Donor-Specific Anti-HLA Antibodies after Kidney Transplantation
por: Jung, Hee-Yeon, et al.
Publicado: (2018)

HLA‐EPI: A new EPIsode in exploring donor/recipient epitopic compatibilities
por: Geffard, Estelle, et al.
Publicado: (2021)

Emerging and Novel Functions of Complement Protein C1q
por: Kouser, Lubna, et al.
Publicado: (2015)

Complement C1q expression in Erythema nodosum leprosum
por: Negera, Edessa, et al.
Publicado: (2018)

Emerging Roles of Complement Protein C1q in Neurodegeneration
por: Cho, Kyoungjoo
Publicado: (2019)

Prognostic Implications of the Complement Protein C1q in Gliomas
por: Mangogna, Alessandro, et al.
Publicado: (2019)

Complement C1q (C1qA, C1qB, and C1qC) May Be a Potential Prognostic Factor and an Index of Tumor Microenvironment Remodeling in Osteosarcoma
por: Chen, Long-hao, et al.
Publicado: (2021)

Risk factors in the progression of BK virus-associated nephropathy in renal transplant recipients
por: Lee, Hae Min, et al.
Publicado: (2015)

De Novo Donor-Specific HLA Antibody Development and Peripheral CD4(+)CD25(high) Cells in Kidney Transplant Recipients: A Place for Interaction?
por: Alberu, Josefina, et al.
Publicado: (2012)

De Novo Donor-Specific HLA Antibodies Developing Early or Late after Transplant Are Associated with the Same Risk of Graft Damage and Loss in Nonsensitized Kidney Recipients
por: Cioni, Michela, et al.
Publicado: (2017)

Association of intraindividual tacrolimus variability with de novo donor-specific HLA antibody development and allograft rejection in pediatric kidney transplant recipients with low immunological risk
por: Baghai Arassi, Maral, et al.
Publicado: (2022)

Association between SARS-CoV-2 infection and de novo HLA donor specific antibody production in lung transplant recipients: Single-center study
por: Shah, Sadia Z., et al.
Publicado: (2022)

Impact of Resolved Preformed, Persistent Preformed, and De Novo Anti-HLA Donor-Specific Antibodies in Kidney Transplant Recipients on Long-Term Renal Graft Outcomes
por: Gniewkiewicz, Michal, et al.
Publicado: (2023)

Influence of Donors’ and Recipients’ HLA Typing on Renal Function Immediately After Kidney Transplantation
por: Rostami, Zohreh, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4buif2m4icdccrhvjnt1i1unkj